Annual Total Liabilities
$267.05 M
-$76.92 M-22.36%
31 December 2023
Summary:
Nektar Therapeutics annual total liabilities is currently $267.05 million, with the most recent change of -$76.92 million (-22.36%) on 31 December 2023. During the last 3 years, it has fallen by -$194.43 million (-42.13%). NKTR annual total liabilities is now -53.31% below its all-time high of $571.97 million, reached on 31 December 2019.NKTR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$259.08 M
-$4.56 M-1.73%
30 September 2024
Summary:
Nektar Therapeutics quarterly total liabilities is currently $259.08 million, with the most recent change of -$4.56 million (-1.73%) on 30 September 2024. Over the past year, it has dropped by -$23.79 million (-8.41%). NKTR quarterly total liabilities is now -56.79% below its all-time high of $599.58 million, reached on 30 September 2019.NKTR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.4% | -8.4% |
| 3 y3 years | -42.1% | -45.5% |
| 5 y5 years | -38.3% | -56.8% |
NKTR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.1% | at low | -45.5% | at low |
| 5 y | 5 years | -53.3% | at low | -56.8% | at low |
| alltime | all time | -53.3% | >+9999.0% | -56.8% | >+9999.0% |
Nektar Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $259.08 M(-1.7%) |
| June 2024 | - | $263.65 M(-2.1%) |
| Mar 2024 | - | $269.31 M(+0.8%) |
| Dec 2023 | $267.05 M(-22.4%) | $267.05 M(-5.6%) |
| Sept 2023 | - | $282.88 M(-4.9%) |
| June 2023 | - | $297.32 M(-7.3%) |
| Mar 2023 | - | $320.88 M(-6.7%) |
| Dec 2022 | $343.96 M(-21.4%) | $343.96 M(-6.7%) |
| Sept 2022 | - | $368.78 M(-8.5%) |
| June 2022 | - | $403.25 M(-3.1%) |
| Mar 2022 | - | $416.23 M(-4.9%) |
| Dec 2021 | $437.68 M(-5.2%) | $437.68 M(-8.0%) |
| Sept 2021 | - | $475.70 M(+2.0%) |
| June 2021 | - | $466.38 M(+0.9%) |
| Mar 2021 | - | $462.06 M(+0.1%) |
| Dec 2020 | $461.47 M(-19.3%) | $461.47 M(+36.7%) |
| Sept 2020 | - | $337.69 M(-0.3%) |
| June 2020 | - | $338.64 M(-42.7%) |
| Mar 2020 | - | $591.51 M(+3.4%) |
| Dec 2019 | $571.97 M(+32.2%) | $571.97 M(-4.6%) |
| Sept 2019 | - | $599.58 M(+10.5%) |
| June 2019 | - | $542.50 M(+1.8%) |
| Mar 2019 | - | $532.97 M(+23.2%) |
| Dec 2018 | $432.60 M(+2.7%) | $432.60 M(-5.7%) |
| Sept 2018 | - | $458.98 M(+1.4%) |
| June 2018 | - | $452.67 M(+3.2%) |
| Mar 2018 | - | $438.51 M(+4.1%) |
| Dec 2017 | $421.04 M(-12.4%) | $421.04 M(-15.4%) |
| Sept 2017 | - | $497.89 M(+5.4%) |
| June 2017 | - | $472.47 M(-2.3%) |
| Mar 2017 | - | $483.74 M(+0.6%) |
| Dec 2016 | $480.75 M(-2.3%) | $480.75 M(-2.5%) |
| Sept 2016 | - | $492.95 M(-1.9%) |
| June 2016 | - | $502.35 M(+2.1%) |
| Mar 2016 | - | $492.15 M(-0.0%) |
| Dec 2015 | $492.21 M(+21.4%) | $492.21 M(+20.0%) |
| Sept 2015 | - | $410.19 M(-2.7%) |
| June 2015 | - | $421.57 M(-0.1%) |
| Mar 2015 | - | $421.91 M(+4.1%) |
| Dec 2014 | $405.29 M(-22.7%) | $405.29 M(-5.7%) |
| Sept 2014 | - | $429.68 M(-16.3%) |
| June 2014 | - | $513.50 M(+3.4%) |
| Mar 2014 | - | $496.82 M(-5.3%) |
| Dec 2013 | $524.43 M(+16.3%) | $524.43 M(+21.0%) |
| Sept 2013 | - | $433.29 M(-4.4%) |
| June 2013 | - | $453.36 M(+0.6%) |
| Mar 2013 | - | $450.52 M(-0.1%) |
| Dec 2012 | $450.77 M(+10.3%) | $450.77 M(+1.0%) |
| Sept 2012 | - | $446.12 M(-16.8%) |
| June 2012 | - | $536.16 M(+0.7%) |
| Mar 2012 | - | $532.30 M(+30.2%) |
| Dec 2011 | $408.74 M(-5.1%) | $408.74 M(-2.1%) |
| Sept 2011 | - | $417.30 M(-0.5%) |
| June 2011 | - | $419.58 M(-0.9%) |
| Mar 2011 | - | $423.24 M(-1.7%) |
| Dec 2010 | $430.56 M(-9.0%) | $430.56 M(+8.9%) |
| Sept 2010 | - | $395.53 M(-6.1%) |
| June 2010 | - | $421.11 M(-5.1%) |
| Mar 2010 | - | $443.75 M(-6.2%) |
| Dec 2009 | $473.15 M | $473.15 M(+36.5%) |
| Sept 2009 | - | $346.55 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $342.40 M(-1.2%) |
| Mar 2009 | - | $346.67 M(-6.4%) |
| Dec 2008 | $370.38 M(-27.5%) | $370.38 M(-19.4%) |
| Sept 2008 | - | $459.72 M(-1.3%) |
| June 2008 | - | $465.79 M(-0.5%) |
| Mar 2008 | - | $468.08 M(-8.3%) |
| Dec 2007 | $510.66 M(-5.6%) | $510.66 M(-10.0%) |
| Sept 2007 | - | $567.38 M(+10.2%) |
| June 2007 | - | $514.78 M(+2.3%) |
| Mar 2007 | - | $503.12 M(-7.0%) |
| Dec 2006 | $541.12 M(+1.8%) | $541.12 M(+0.5%) |
| Sept 2006 | - | $538.34 M(-4.2%) |
| June 2006 | - | $561.88 M(+5.1%) |
| Mar 2006 | - | $534.73 M(+0.6%) |
| Dec 2005 | $531.74 M(+91.6%) | $531.74 M(+3.7%) |
| Sept 2005 | - | $512.81 M(+88.0%) |
| June 2005 | - | $272.73 M(+0.9%) |
| Mar 2005 | - | $270.18 M(-2.7%) |
| Dec 2004 | $277.58 M(-38.7%) | $277.58 M(+6.4%) |
| Sept 2004 | - | $260.96 M(-1.0%) |
| June 2004 | - | $263.56 M(-4.6%) |
| Mar 2004 | - | $276.20 M(-39.0%) |
| Dec 2003 | $452.60 M(+13.2%) | $452.60 M(-4.6%) |
| Sept 2003 | - | $474.33 M(+3.2%) |
| June 2003 | - | $459.82 M(+22.1%) |
| Mar 2003 | - | $376.61 M(-5.8%) |
| Dec 2002 | $399.87 M(+0.7%) | $399.87 M(+2.6%) |
| Sept 2002 | - | $389.88 M(-1.3%) |
| June 2002 | - | $394.83 M(-0.4%) |
| Mar 2002 | - | $396.54 M(-0.1%) |
| Dec 2001 | $396.93 M(+12.9%) | $396.93 M(+3.6%) |
| Sept 2001 | - | $383.10 M(-2.7%) |
| June 2001 | - | $393.86 M(+7.4%) |
| Mar 2001 | - | $366.61 M(+4.3%) |
| Dec 2000 | $351.66 M(+150.9%) | $351.66 M(+32.1%) |
| Sept 2000 | - | $266.16 M(-3.2%) |
| June 2000 | - | $275.06 M(-1.2%) |
| Mar 2000 | - | $278.42 M(+98.6%) |
| Dec 1999 | $140.18 M(+653.0%) | $140.18 M(+530.7%) |
| Sept 1999 | - | $22.22 M(+2.9%) |
| June 1999 | - | $21.61 M(+5.0%) |
| Mar 1999 | - | $20.57 M(+10.5%) |
| Dec 1998 | $18.61 M(-17.9%) | $18.61 M(+15.1%) |
| Sept 1998 | - | $16.17 M(-14.1%) |
| June 1998 | - | $18.83 M(-7.4%) |
| Mar 1998 | - | $20.34 M(-10.3%) |
| Dec 1997 | $22.67 M(+254.2%) | $22.67 M(+51.1%) |
| Sept 1997 | - | $15.00 M(+17.3%) |
| June 1997 | - | $12.79 M(+36.2%) |
| Mar 1997 | - | $9.39 M(+46.7%) |
| Dec 1996 | $6.40 M(+113.3%) | $6.40 M(+82.9%) |
| Sept 1996 | - | $3.50 M(+6.1%) |
| June 1996 | - | $3.30 M(+13.8%) |
| Mar 1996 | - | $2.90 M(-3.3%) |
| Dec 1995 | $3.00 M(+66.7%) | $3.00 M(+15.4%) |
| Sept 1995 | - | $2.60 M(-3.7%) |
| June 1995 | - | $2.70 M(-10.0%) |
| Mar 1995 | - | $3.00 M(+66.7%) |
| Dec 1994 | $1.80 M | $1.80 M(-30.8%) |
| Sept 1994 | - | $2.60 M(+18.2%) |
| June 1994 | - | $2.20 M(+4.8%) |
| Mar 1994 | - | $2.10 M |
FAQ
- What is Nektar Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics annual total liabilities year-on-year change?
- What is Nektar Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly total liabilities year-on-year change?
What is Nektar Therapeutics annual total liabilities?
The current annual total liabilities of NKTR is $267.05 M
What is the all time high annual total liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high annual total liabilities is $571.97 M
What is Nektar Therapeutics annual total liabilities year-on-year change?
Over the past year, NKTR annual total liabilities has changed by -$76.92 M (-22.36%)
What is Nektar Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NKTR is $259.08 M
What is the all time high quarterly total liabilities for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly total liabilities is $599.58 M
What is Nektar Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NKTR quarterly total liabilities has changed by -$23.79 M (-8.41%)